132 related articles for article (PubMed ID: 6340757)
1. Markedly elevated serum IgE levels following allogeneic and syngeneic bone marrow transplantation.
Ringdén O; Persson U; Johansson SG; Wilczek H; Gahrton G; Groth CG; Lundgren G; Lönnqvist B; Möller E
Blood; 1983 Jun; 61(6):1190-5. PubMed ID: 6340757
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin E levels following allogeneic, autologous, and syngeneic bone marrow transplantation: an indirect association between hyperproduction and acute graft-v-host disease in allogeneic BMT.
Heyd J; Donnenberg AD; Burns WH; Saral R; Santos GW
Blood; 1988 Aug; 72(2):442-6. PubMed ID: 3042039
[TBL] [Abstract][Full Text] [Related]
3. Transient elevation of serum IgE after allogeneic bone-marrow transplantation.
Korver K; Schellekens PT; Dooren LJ; Vossen JM
Int Arch Allergy Appl Immunol; 1987; 84(1):45-55. PubMed ID: 3305375
[TBL] [Abstract][Full Text] [Related]
4. Recovery of immunoglobulin isotypes following T-cell depleted allogeneic bone marrow transplantation.
Brenner MK; Wimperis JZ; Reittie JE; Patterson J; Asherson GL; Hoffbrand AV; Prentice HG
Br J Haematol; 1986 Sep; 64(1):125-32. PubMed ID: 3530313
[TBL] [Abstract][Full Text] [Related]
5. Regulation of human immunoglobulin E synthesis in acute graft versus host disease.
Saryan JA; Rappeport J; Leung DY; Parkman R; Geha RS
J Clin Invest; 1983 Mar; 71(3):556-64. PubMed ID: 6338041
[TBL] [Abstract][Full Text] [Related]
6. Are increased IgE-levels a signal of an acute graft-versus-host reaction?
Ringdén O; Persson U; Johansson SG
Immunol Rev; 1983; 71():57-75. PubMed ID: 6343226
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of presumed sepsis from acute graft-versus-host disease by C-reactive protein and serum total IgE in bone marrow transplant recipients.
Saarinen UM; Strandjord SE; Warkentin PI; Cheung NK; Lazarus HM; Coccia PF
Transplantation; 1987 Oct; 44(4):540-6. PubMed ID: 3313843
[TBL] [Abstract][Full Text] [Related]
8. Increased serum immunoglobulin E levels following allogeneic bone marrow transplantation.
Geha RS; Rappaport JM; Twarog FJ; Parkman R; Rosen FS
J Allergy Clin Immunol; 1980 Jul; 66(1):78-81. PubMed ID: 6991585
[TBL] [Abstract][Full Text] [Related]
9. Serum immunoglobulin levels following allogeneic bone marrow transplantation.
Perreault C; Giasson M; Gyger M; Belanger R; David M; Bonny Y; Boileau J; Barcelo R; Moquin JP
Blut; 1985 Sep; 51(3):137-42. PubMed ID: 3896351
[TBL] [Abstract][Full Text] [Related]
10. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
[TBL] [Abstract][Full Text] [Related]
11. Serum IgE levels after bone marrow transplantation.
Abedi MR; Bäckman L; Persson U; Ringdén O
Bone Marrow Transplant; 1989 May; 4(3):255-60. PubMed ID: 2659111
[TBL] [Abstract][Full Text] [Related]
12. [Bone marrow transplantation in severe aplastic anemia and acute leukemia].
Speck B; Sartorius J; Cornu P; Nissen C; Weber W; Gratwohl A
Onkologie; 1979 Apr; 2(2):79-82. PubMed ID: 42865
[TBL] [Abstract][Full Text] [Related]
13. Marrow transplant experience for children with severe aplastic anemia.
Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
[TBL] [Abstract][Full Text] [Related]
14. Studies on cellular inhibition and serum-blocking factors in 28 human patients given marrow grafts from HLA identical siblings.
Tsoi MS; Storb R; Weiden PL; Thomas ED
J Immunol; 1977 May; 118(5):1799-805. PubMed ID: 16061
[TBL] [Abstract][Full Text] [Related]
15. Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humans.
Hinterberger-Fischer M; Kier P; Spona J; Sebesta C; Tiefengraber E; Habertheuer KH; Ruckser R; Schmid A; Kalhs P; Lechner K
Bone Marrow Transplant; 1994 Sep; 14(3):403-6. PubMed ID: 7994262
[TBL] [Abstract][Full Text] [Related]
16. Acute graft-versus-host disease after allogeneic bone marrow transplantation.
Perreault C; Gyger M; Boileau J; Bonny Y; Cousineau S; Lacombe M; Lavallee R; Tawil E; D'Angelo G
Can Med Assoc J; 1983 Nov; 129(9):969-74. PubMed ID: 6367917
[TBL] [Abstract][Full Text] [Related]
17. Comparisons between allogeneic peripheral blood stem cell transplantation and allogeneic bone marrow transplantation in adult hematologic disease: a single center experience.
Liu YC; Chang CS; Liu TC; Chen TP; Sue YC; Hsiao HH; Lin SF
Kaohsiung J Med Sci; 2003 Nov; 19(11):541-8. PubMed ID: 14658482
[TBL] [Abstract][Full Text] [Related]
18. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
[TBL] [Abstract][Full Text] [Related]
19. Some but not all benefits of intravenous immunoglobulin therapy after marrow transplantation appear to correlate with IgG trough levels.
Cottler-Fox M; Lynch M; Pickle LW; Cahill R; Spitzer TR; Deeg HJ
Bone Marrow Transplant; 1991 Jul; 8(1):27-33. PubMed ID: 1655138
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplantation for severe aplastic anemia. A report of 9 cases.
Marmont AM; Van Lint MT; Avanzi G; Reali G; Adami R; Soldá A; Strada P; Barbanti M; Mingari MC; Soro O; Grazi G; Pedullá D; Cerri R; Rossi E; Giordano D; Santini G; Carella A; Risso M; Vimercati R; Piaggio G; Raffo MR; Librace E; Vitale V; Bacigalupo A
Acta Haematol; 1979; 62(3):121-7. PubMed ID: 43062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
